Evidence map›Paper›PMID 27677260›Full record

ArticleGenome biology2016

GNB5 mutation causes a novel neuropsychiatric disorder featuring attention deficit hyperactivity disorder, severely impaired language development and normal cognition.

Hanan E Shamseldin, Ikuo Masuho, Ahmed Alenizi, Suad Alyamani, Dipak N Patil, Niema Ibrahim, Kirill A Martemyanov, Fowzan S Alkuraya

Open access · goldAbstract read
In one paragraph

Article in Genome biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Hanan E ShamseldinDepartment of Genetics, King Faisal Specialist Hospital and Research Center, MBC-03, PO Box 3354, Riyadh, 11211, Saudi Arabia.
Ikuo MasuhoDepartment of Neuroscience, The Scripps Research Institute, 130 Scripps Way, #3C2, Jupiter, FL, 33458, USA.
Ahmed AleniziDepartment of Pediatrics, King Saud Medical City, Riyadh, Saudi Arabia.
Suad AlyamaniDepartment of Neurosciences, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Dipak N PatilDepartment of Neuroscience, The Scripps Research Institute, 130 Scripps Way, #3C2, Jupiter, FL, 33458, USA.
Niema IbrahimDepartment of Genetics, King Faisal Specialist Hospital and Research Center, MBC-03, PO Box 3354, Riyadh, 11211, Saudi Arabia.
Kirill A MartemyanovDepartment of Neuroscience, The Scripps Research Institute, 130 Scripps Way, #3C2, Jupiter, FL, 33458, USA. Kirill@scripps.edu.
Fowzan S AlkurayaDepartment of Genetics, King Faisal Specialist Hospital and Research Center, MBC-03, PO Box 3354, Riyadh, 11211, Saudi Arabia. falkuraya@kfshrc.edu.sa.
King Faisal Specialist Hospital & Research Centre · SAScripps Research Institute · USAlfaisal University · SAKing Saud Medical City · SA

Funding

Regulation of Striatal Signaling by RGS ProteinsR01DA036596 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Kirill A. Martemyanov · 2014 to 2026
$6.5M
Orphan Receptors in Regulation of Neuronal G Protein SignalingR01MH105482 · NIMH · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Kirill A. Martemyanov · 2015 to 2026
$6.1M
Dopamine D1 Receptor in mouse models of primary dystoniaR01NS081282 · NINDS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI EHRLICH, MICHELLE E, MARTEMYANOV, KIRILL A. · 2013 to 2017
$2.5M
Molecular Basis of RGS Protein Function in the StriatumK02DA026405 · NIDA · UNIVERSITY OF MINNESOTA · PI MARTEMYANOV, KIRILL A. · 2009 to 2019
$1.2M
NIDA NIH HHS K02 DA026405NIDA NIH HHS R01 DA036596NIMH NIH HHS R01 MH105482NINDS NIH HHS R01 NS081282
6 · The paper itself

Abstract

backgroundNeuropsychiatric disorders are common forms of disability in humans. Despite recent progress in deciphering the genetics of these disorders, their phenotypic complexity continues to be a major challenge. Mendelian neuropsychiatric disorders are rare but their study has the potential to unravel novel mechanisms that are relevant to their complex counterparts.

resultsIn an extended consanguineous family, we identified a novel neuropsychiatric phenotype characterized by severe speech impairment, variable expressivity of attention deficit hyperactivity disorder (ADHD), and motor delay. We identified the disease locus through linkage analysis on 15q21.2, and exome sequencing revealed a novel missense variant in GNB5. GNB5 encodes an atypical β subunit of the heterotrimeric GTP-binding proteins (Gβ5). Gβ5 is enriched in the central nervous system where it forms constitutive complexes with members of the regulator of G protein signaling family of proteins to modulate neurotransmitter signaling that affects a number of neurobehavioral outcomes. Here, we show that the S81L mutant form of Gβ5 has significantly impaired activity in terminating responses that are elicited by dopamine.

conclusionsWe demonstrate that these deficits originate from the impaired expression of the mutant Gβ5 protein, resulting in the decreased ability to stabilize regulator of G protein signaling complexes. Our data suggest that this novel neuropsychiatric phenotype is the human equivalent of Gnb5 deficiency in mice, which manifest motor deficits and hyperactivity, and highlight a critical role of Gβ5 in normal behavior as well as language and motor development in humans.

Indexed as

Attention deficit hyperactivity disorder (ADHD)G protein coupled receptors (GPCR)HippocampusLinkageMendelianNeuropsychiatric disordersStriatum

Identifiers

PMID27677260
PMCPMC5037613
OpenAlexW2524122176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.